A one-hour intravesical treatment (confined to the bladder and instilled via a catheter) of gemcitabine or mitomycin chemotherapy is common at the end of the TURBT surgery to destroy any cancer cells still remaining. When there is a shortage of BCG at your treatment location, gemcitabine may be offered as a substitute for weekly immunotherapy treatment. BCG is normally used for only high-grade, non-invasive muscle disease (TA, T1 and CIS). Not clear on your hair loss question.
12/15 - Diagnosed Ta HG, 1.5cm Pap, Focal CIS
3/16 - Began BCG following NCCN and SWOG guidelines
2/19 - Ta HG recurrence and CIS/Ta HG in right kidney/ureter
2/19 - Nephroureterectomy to remove right kidney/ureter
9/19 - BCGx33 completed
2/20 - Invasive HG urothelial pT2 in prostate stroma